News
New Publishing in OBM Transplantation
Advances in Human Islet Processing: Manufacturing Steps to Achieve Predictable Islet Outcomes from Research Pancreases David W. Scharp, Jayagowri Arulmoli, Kelly Morgan, Hannah Sunshine, Ergeng Hao Received: October 15, 2018; Published: February 26, 2019; doi:...
PIM Complete
March 13, 2018-Prodo is excited to announce PIM Complete! PIM Complete is a simplified way to order the base medium (R-Recovery, S-Standard or T-Transport) and all of the required supplements (ABS-Human AB Serum, G-Glutamine/Glutathione and 3X-Triple Antibiotics)...
New Antibiotic Supplement
March, 2018-Prodo Labs is excited to announce its new, antibiotic supplement PIM(3X)! PIM(3X) is a cGMP triple antibiotic mixture designed to supplement PIM(R), PIM(S) and PIM(T). For more information, please click HERE.
Sponsoring Workshop
January, 2018 - Prodo Laboratories will be happily sponsoring the IIDP’s Human Islet Workshop at the 2018 Rachmiel Levine Diabetes Research Symposium in Pasadena, CA.
Exhibit for Diabetes Research
March, 2017 - Prodo Laboratories will be exhibiting at the 2017 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium. If attending, please stop by to say hello. We will be discussing our new products that are about to be released to the diabetes research community.
January, 2016
Prodo Laboratories has moved into a new research building, expanding its operations and capabilities in the diabetes research community.
December, 2015
Prodo Islet Media is now being shipped globally and is the preferred solution for islet culturing.
May, 2015
Prodo Labs continues to globally ship human islets on a weekly basis, with over 60 million IEQ sent to academic and corporate investigators in over 30 countries.
March 7th, 2012
The Food and Drug Administration has granted Prodo Laboratories, Inc. a Biological Master File number for the Prodo Islet Media (PIM)®! The BMF number is IND-15016. Clinical testing is approved and underway at several isolation centers.
November 3, 2011
University of Pittsburgh releases poster showing that Prodo Islet Media outperforms CRML Media
November 2, 2011
Transplantation Center testing confirms that Prodo Islet Media out performs CRML based media by a considerable margin. Worldwide testing is underway at additional centers.
October 23, 2011
Prodo Laboratories is the recipient of a Phase I, NIH/SBIR Grant for Islet Encapsulation.
September 12, 2011
Prodo Labs hits the 21 million IEQ shipped mark.
June 1, 2011
Prodo Labs officially launched their cGMP Islet Culture Media (Prodo Islet Media-PIM) at the International Pancreas and Islet Transplant Association meeting in Prague. Please visit our cGMP Products section for more information.
February 14, 2011
Prodo Labs has now shipped over 16 million islets to both the corporate and academic communities, with purity averaging 85-90% and viability averaging 95%.
November 5, 2010
Prodo Labs announces being the recipient of two new grants from the Qualifying Therapeutic Discovery Grant (QTDG) funds from a combined NIH/IRS program to provide stimulus funds to small businesses working to develop new health care products. The first grant is for...
October 1, 2010
Prodo Labs announces its ability to begin supplying human islets from Type 2 Diabetes research pancreas donors directly to corporate and academic investigators. There is a need for supplying human islets processed from Type 2 Diabetes pancreases. These are obtained...
July 1, 2010
Prodo Labs publishes a new article in Transplantation Proceedings regarding its success in processing large quantities of human islets from research pancreas donors with long cold ischemia times. Prodo Labs has published its most recent results of processing and...
April 21, 2010
Prodo Labs and the Scharp-Lacy Research Institute collaborate to increase the numbers of high quality human islets for distribution through a new contract with the National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) of the National Institutes of...
October 15, 2009
Prodo Labs announces cut back in activities due to reduced islet orders from the economic turndown. With slow down in the economy, major corporate pharmaceutical companies are changing their priorities in their research operations and reducing the number of human...
March 18, 2009
Prodo Labs presented at the Rochmeil Levine Symposium A paper entitled, "USE OF ROCHE cGMP LIBERASE® MTF C/T IN ISLET ISOLATION FROM HUMAN PANCREAS WITH EXTENDED COLD ISCHEMIA TIME (CIT), was presented at the City of Hope annual Levine Symposium. It demonstrated the...
July 1, 2008
Prodo Labs announces that its contracts for the distribution of human islets for research have reached pharmaceutical companies with a total annual R&D budget of $26 Billion. Prodo Labs provides human islets for research to biotechnology and pharmaceutical...
June 23, 2008
The Scharp –Lacy Institute replaces the Invenio Institute and takes control of its contract with the JDRF to supply human islets for research to its funded investigators. Invenio Institute has decided to change its name to The Scharp-Lacy Research Institute to capture...
April, 2008
Invenio Institute Awarded Contract by Juvenile Diabetes Research Foundation (JDRF) to Distribute Human Islets for Research to Their Funded Investigators. The JDRF has renewed a contract with Invenio Institute to distribute human islets which had distributed 5 million...
September 16, 2007
Prodo Laboratories, Inc. launches two new products at the International Pancreas and Islet Transplant Association (IPITA) Conference in Minneapolis. Prodo Labs is launching two new tissue culture products specifically designed for islets at the international IPITA...
July 15, 2007
Prodo Labs Announces Acceptance of Small Business Administration Loan. Prodo Laboratories, Inc is pleased to announce that its application to the U.S. Small Business Administration (SBA) has been accepted with a loan from Plaza Bank, Irvine, CA for $300,000 to...
July 5, 2007
Prodo Laboratories, Inc. begins processing human pancreases. Prodo Labs begins operations today by processing its first human pancreas into viable human islets to be sent to diabetes researchers to assist their efforts to help patients with diabetes. After many months...
June 1, 2007
Invenio Institute receives contract from Juvenile Diabetes Research Foundation to provide human islets for JDRF and NIH diabetes researchers. Invenio Institute was awarded a research contract to distribute human islets for research to academic investigators needing...
November 16, 2006
Prodo Laboratories Inc. and Invenio Insitute are announced at the Rachmiel Levine Diabetes and Obesity Symposium. Irvine, Ca. Two new diabetes companies, Prodo Laboratories, Inc. and Invenio Institute, announced their launch at the Rachmiel Levine Diabetes and Obesity...
November 1, 2006
Prodo Laboratories, Inc and Invenio Institute rent office space. Prodo Laboratories and Invenio Institute have rented a two story 8,100 sq ft office suite with warehouse at 32A Mauchly, Irvine, CA 92618 to be developed into a research and development facility....
September 19, 2006
Invenio Institute founded. Invenio Institute has been founded as a California public benefit company to function as a not-for-profit research institute to perform diabetes research that will lead to new products for patients with diabetes
September 11, 2006
Prodo Laboratories, Inc. founded. Prodo Laboratories, Inc was founded today founded as a Delaware corporation intending to operate as a for-profit diabetes biotechnology company to develop products for diabetes researchers and for patients with diabetes.
We’ve Moved!
January, 2016 – Prodo Laboratories has moved into a new research building, expanding its operations and capabilities in the diabetes research community.